“Trump Administration Reverses Kratom Ban After Industry Lobbying, Raising Safety Concerns ” — what this page in the network covers. The Trump administration has reversed its proposed ban on kratom, an herbal supplement with opioid-like effects, following intense lobbying from the kratom industry. Health officials will now permit certain levels of the substance in products marketed as natural, a significant shift from earlier pla Health officials will now permit certain levels of the substance in products marketed as natural, a significant shift from earlier plans to classify kratom as a Schedule I drug.
The decision comes amid growing public debate over kratom's safety and potential for addiction, with proponents citing its use for pain relief and opioid withdrawal, while critics warn of health risks and deaths linked to its use. The reversal could benefit a major Republican donor who faces wrongful death lawsuits connected to kratom products, raising questions about political influence on public health policy. This listing links straight to the original page, where the content is available in full.